HUT70942A - Tris carbamic acid esters as inhibitors of cholesterol absorption and pharmaceutical compositions containing them - Google Patents
Tris carbamic acid esters as inhibitors of cholesterol absorption and pharmaceutical compositions containing themInfo
- Publication number
- HUT70942A HUT70942A HU9402108A HU9402108A HUT70942A HU T70942 A HUT70942 A HU T70942A HU 9402108 A HU9402108 A HU 9402108A HU 9402108 A HU9402108 A HU 9402108A HU T70942 A HUT70942 A HU T70942A
- Authority
- HU
- Hungary
- Prior art keywords
- tris
- inhibitors
- pharmaceutical compositions
- acid esters
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/095,140 US5952354A (en) | 1993-07-21 | 1993-07-21 | Tris carbamic acid esters: inhibitors of cholesterol absorption |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU9402108D0 HU9402108D0 (en) | 1994-09-28 |
| HUT70942A true HUT70942A (en) | 1995-11-28 |
| HU216790B HU216790B (hu) | 1999-08-30 |
Family
ID=22250071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9402108A HU216790B (hu) | 1993-07-21 | 1994-07-15 | Koleszterin abszorpcióját gátló hatású trisz(karbaminsav-észter)-származékok, és ezeket tartalmazó gyógyszerkészítmények |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5952354A (hu) |
| EP (1) | EP0635501A1 (hu) |
| JP (1) | JPH0789934A (hu) |
| KR (1) | KR950003269A (hu) |
| AU (1) | AU692157B2 (hu) |
| BR (1) | BR9402852A (hu) |
| CA (1) | CA2128116A1 (hu) |
| FI (1) | FI943441A (hu) |
| HU (1) | HU216790B (hu) |
| IL (1) | IL110302A (hu) |
| MX (1) | MX9405430A (hu) |
| NZ (1) | NZ264032A (hu) |
| RU (1) | RU2130928C1 (hu) |
| SG (1) | SG47596A1 (hu) |
| TW (1) | TW369527B (hu) |
| ZA (1) | ZA945214B (hu) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5527804A (en) * | 1994-06-13 | 1996-06-18 | American Home Products Corporation | 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors or cholesterol absorption |
| HUP9900617A3 (en) | 1995-10-05 | 2001-12-28 | Kyoto Pharma Ind | Novel indole-, indoline- or tetrahydrokinoline derivatives as acat and lipid peroxidation inhibitors, use thereof, pharmaceutical compositions containing these compounds |
| US5952506A (en) * | 1997-04-24 | 1999-09-14 | American Home Products Corporation | Process for the synthesis of 4- 6- (hexylcarbamoyloxy) hexylcarbamoyloxy!-piperidine-1-carboxylic acid 4-phenoxyphenyl ester |
| WO1998047870A1 (en) * | 1997-04-24 | 1998-10-29 | American Home Products Corporation | Process for the synthesis of 4-[6-(hexylcarbamoyloxy) hexylcarbamoyloxy]-piperidine-1- carboxylic acid 4-phenoxyphenyl ester |
| US20100324075A1 (en) * | 2007-12-21 | 2010-12-23 | University Of Cincinnati | Therapeutic use of carboxyl ester lipase inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2800105A1 (de) * | 1977-01-11 | 1978-07-13 | Ciba Geigy Ag | Verwendung von diphenylaethern als algizide |
| JPS5671058A (en) * | 1979-11-12 | 1981-06-13 | Mitsui Toatsu Chem Inc | Phenoxyphenylcarbamic ester derivative |
| DE3702876A1 (de) * | 1987-01-31 | 1988-08-11 | Merck Patent Gmbh | Optisch aktive verbindungen |
| FR2612186B1 (fr) * | 1987-03-09 | 1989-07-21 | Poudres & Explosifs Ste Nale | Carbonyl 2,2' bis (alkyl-4 oxadiazolidines-1,2,4-diones-3,5), leur procede de preparation et leur utilisation comme intermediaires de synthese dans la preparation de carbamates |
| US5142094A (en) * | 1989-11-06 | 1992-08-25 | Warner-Lambert Company | Aryl substituted carbamate derivatives which are acat inhibitors |
| IL95994A0 (en) * | 1989-11-15 | 1991-07-18 | American Home Prod | Carbamate esters and pharmaceutical compositions containing them |
| US5112859A (en) * | 1990-09-14 | 1992-05-12 | American Home Products Corporation | Biphenyl amide cholesterol ester hydrolase inhibitors |
| US5169844A (en) * | 1991-12-20 | 1992-12-08 | American Home Products Corporation | 4-substituted piperidinecarboxylic acid esters: inhibition of cholesterol absorption |
-
1993
- 1993-07-21 US US08/095,140 patent/US5952354A/en not_active Expired - Fee Related
-
1994
- 1994-01-10 TW TW083100154A patent/TW369527B/zh active
- 1994-07-13 IL IL110302A patent/IL110302A/en not_active IP Right Cessation
- 1994-07-15 RU RU94026296A patent/RU2130928C1/ru active
- 1994-07-15 CA CA002128116A patent/CA2128116A1/en not_active Abandoned
- 1994-07-15 ZA ZA945214A patent/ZA945214B/xx unknown
- 1994-07-15 MX MX9405430A patent/MX9405430A/es unknown
- 1994-07-15 HU HU9402108A patent/HU216790B/hu not_active IP Right Cessation
- 1994-07-18 NZ NZ264032A patent/NZ264032A/en unknown
- 1994-07-18 AU AU67520/94A patent/AU692157B2/en not_active Ceased
- 1994-07-18 JP JP6165075A patent/JPH0789934A/ja active Pending
- 1994-07-18 BR BR9402852A patent/BR9402852A/pt not_active Application Discontinuation
- 1994-07-18 KR KR1019940017234A patent/KR950003269A/ko not_active Application Discontinuation
- 1994-07-19 EP EP94305305A patent/EP0635501A1/en not_active Ceased
- 1994-07-19 SG SG1996003025A patent/SG47596A1/en unknown
- 1994-07-20 FI FI943441A patent/FI943441A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR950003269A (ko) | 1995-02-16 |
| HU216790B (hu) | 1999-08-30 |
| SG47596A1 (en) | 1998-04-17 |
| RU2130928C1 (ru) | 1999-05-27 |
| AU6752094A (en) | 1995-02-02 |
| US5952354A (en) | 1999-09-14 |
| ZA945214B (en) | 1996-01-15 |
| IL110302A (en) | 1998-06-15 |
| TW369527B (en) | 1999-09-11 |
| IL110302A0 (en) | 1994-10-21 |
| JPH0789934A (ja) | 1995-04-04 |
| EP0635501A1 (en) | 1995-01-25 |
| AU692157B2 (en) | 1998-06-04 |
| FI943441A (fi) | 1995-01-22 |
| RU94026296A (ru) | 1997-05-27 |
| FI943441A0 (fi) | 1994-07-20 |
| NZ264032A (en) | 1995-12-21 |
| HU9402108D0 (en) | 1994-09-28 |
| CA2128116A1 (en) | 1995-01-22 |
| MX9405430A (es) | 1995-01-31 |
| BR9402852A (pt) | 1995-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL86464A (en) | 4-phosphinyl-3- hydroxybutanoic acid derivatives useful as cholesterol biosynthesis inhibitors and pharmaceutical compositions containing the same | |
| IL103932A (en) | Fatty acid and pharmaceutical compositions containing them | |
| AU7672294A (en) | Compositions and methods for the administration of delta-aminolevulinic acid | |
| AU588968B2 (en) | Pyrrolidineamide derivative of acylamino acid and pharmaceutical composition containing the same | |
| FI940874A0 (fi) | Menetelmä maitohapon ja maitohappoestereiden valmistamiseksi | |
| EP0152217A3 (en) | Liquid crystalline carbonic acid esters and liquid crystal compositions containing them | |
| DE69302098D1 (de) | Zusammensetzungen von hexitan-fettsäureestern | |
| ITMI922721A0 (it) | Composizioni farmaceutiche contenenti acido ursodesossicolico | |
| AU5323694A (en) | 17beta -carboxanilides of 4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors | |
| HUT70942A (en) | Tris carbamic acid esters as inhibitors of cholesterol absorption and pharmaceutical compositions containing them | |
| HUP9700810A3 (en) | Acids and esters of diosmetin and pharmaceutical compositions containing them | |
| PT82339A (en) | Process for the preparation of novel androstane-17beta-carboxylic acid esters and of pharmaceutical compositions containing the same | |
| AU3425193A (en) | 4-substituted piperidinecarboxylic acid esters: inhibition of cholesterol absorption | |
| AU5464094A (en) | Cosmetic composition containing succinic acid esters | |
| HUT60260A (en) | Process for producing carbamic acid derivatives of piperidine and pharmaceutical compositions comprising same | |
| AU4340796A (en) | Use of lauric acid esters as potency increasing agents for active substances | |
| NZ236061A (en) | Phenoxyphenyl esters of carbamic acid derivatives and pharmaceutical compositions | |
| IL108920A0 (en) | Acyloxyhexanoic acid derivatives and pharmaceutical compositions containing them | |
| NZ217724A (en) | Esters of dihydrolysergic acid and pharmaceutical composition | |
| HU9400325D0 (en) | Process for producing amino-ascorbic acid derivatives and pharmaceutical compositions containing them | |
| ZA942082B (en) | Boronic acid and ester inhibitors of thrombin | |
| HUT44005A (en) | Insecticide and acaricide compositions containing esters of carbamic acids as active components and process for producing the active components | |
| AU1067995A (en) | Use of carbamide acid esters as crystallisation inhibitors | |
| PL303822A1 (en) | Therapeutic compositions containing ipsapyrone and method of obtaining them | |
| AU7994294A (en) | Use of phosphonic acid esters as crystallization inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HMM4 | Cancellation of final prot. due to non-payment of fee |